Ann Conkle
May 3, 2012

Cipla lowers generic price of Bayer's Nexavar

Indian drugmaker Cipla cut the price of its generic version of Bayer's cancer drug Nexavar by 75 percent, nearly two months after India allowed another drugmaker to make a cut-rate version of the drug over Bayer's objections.

UPDATE 1-India Cipla slashes generic price of Bayer's Nexavar | Reuters
* To sell generic Nexavar at 6,840 rupees/month* Cuts prices of lung, brain cancer drugs by up to 75 pct* Says price cuts not to hit revenuesBy Kaustubh KulkarniMUMBAI, May 3 (Reuters) - Indian drugmaker